Business Context and Reporting Period
This Form 8-K is filed by IMMUNIC, INC. (IMUX), a Delaware corporation, for the reporting period of June 27, 2025. The filing addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price, which has traded below the $1.00 per share minimum bid price requirement for the last 30 consecutive business days.
Material Changes
- Listing Compliance Deficiency: The Company received a Notice Letter from Nasdaq citing non-compliance with Listing Rule 5450(a)(1) due to the sustained low stock price.
- Compliance Timeline: The Company has been granted an Initial Compliance Period of 180 calendar days, ending on December 24, 2025, to regain compliance.
- Current Listing Status: The notice has no immediate effect on the listing of the Company's common stock on The Nasdaq Global Select Market.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the closing bid price and is evaluating available options to regain compliance. The filing explicitly states there can be no assurance that the Company will be able to regain compliance or remain in compliance with other listing standards.
Path to Compliance:
- The Company can regain compliance if the closing bid price is at least $1.00 for a minimum of 10 consecutive business days.
- If the Initial Compliance Period expires without compliance, the Company may apply for an additional compliance period. This requires meeting the market value of publicly held shares requirement and other initial listing standards (except the bid price).
- Regaining compliance during an additional period may require effecting a reverse stock split.
Risks: Failure to regain compliance by the end of the applicable compliance period will result in written notification that the securities are subject to delisting.
Investor Verification Checklist
- Verify the current closing bid price of IMUX stock relative to the $1.00 threshold.
- Monitor the Company's announcements regarding the potential execution of a reverse stock split.
- Check for any subsequent filings indicating the Company has met the 10-day consecutive trading requirement to regain compliance.
- Review the Company's market value of publicly held shares to assess eligibility for an additional compliance period if the initial period expires.